{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T14:56:19Z","timestamp":1763564179150},"reference-count":16,"publisher":"Japanese Society for Lymphoreticular Tissue Research","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCEH","J Clin Exp Hematopathol"],"published-print":{"date-parts":[[2022]]},"DOI":"10.3960\/jslrt.21026","type":"journal-article","created":{"date-parts":[[2021,10,25]],"date-time":"2021-10-25T22:10:27Z","timestamp":1635199827000},"page":"52-57","source":"Crossref","is-referenced-by-count":2,"title":["A sporadic case of CTLA4 haploinsufficiency manifesting as Epstein\u2013Barr virus-positive diffuse large B-cell lymphoma"],"prefix":"10.3960","volume":"62","author":[{"given":"Hepei","family":"Yuan","sequence":"first","affiliation":[{"name":"Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Momoko","family":"Nishikori","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiyoko","family":"Ueda","sequence":"additional","affiliation":[{"name":"Department of Hematology, Kyoto Katsura Hospital, Kyoto Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masakazu","family":"Fujimoto","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Pathology, Kyoto University Hospital, Kyoto, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Yasumi","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Graduate School of Medicine, Kyoto University, Kyoto, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuyuki","family":"Otsuka","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshio","family":"Kitawaki","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Hirata","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Pathology, Kyoto University Hospital, Kyoto, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hironori","family":"Haga","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Pathology, Kyoto University Hospital, Kyoto, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirokazu","family":"Kanegane","sequence":"additional","affiliation":[{"name":"Department of Child Health and Development, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akifumi","family":"Takaori-Kondo","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2349","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Leach DR, Krummel MF, Allison JP. Enhancement of antitumor immunity by CTLA-4 blockade. Science. 1996; 271: 1734-1736.","DOI":"10.1126\/science.271.5256.1734"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Wolchok JD, Kluger H, Callahan MK <i>et al.<\/i> Nivolumab plus ipilimumab in advanced melanoma. N Engl J Med. 2013; 369: 122-133.","DOI":"10.1056\/NEJMoa1302369"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Schubert D, Bode C, Kenefeck R <i>et al.<\/i> Autosomal dominant immune dysregulation syndrome in humans with CTLA4 mutations. Nat Med. 2014; 20: 1410-1416.","DOI":"10.1038\/nm.3746"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Kuehn HS, Ouyang W, Lo B <i>et al.<\/i> Immune dysregulation in human subjects with heterozygous germline mutations in CTLA4. Science. 2014; 345: 1623-1627.","DOI":"10.1126\/science.1255904"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Schwab C, Gabrysch A, Olbrich P <i>et al.<\/i> Phenotype, penetrance, and treatment of 133 cytotoxic T-lymphocyte antigen 4\u2013insufficient subjects. J Allergy Clin Immunol. 2018; 142: 1932-1946.","DOI":"10.1016\/j.jaci.2018.02.055"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Kanegane H, Hoshino A, Okano T <i>et al.<\/i> Flow cytometry-based diagnosis of primary immunodeficiency diseases. Allergol Int. 2018; 67: 43-54.","DOI":"10.1016\/j.alit.2017.06.003"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Rieux-Laucat F, Casanova JL. Autoimmunity by haploinsufficiency. Science. 2014; 345: 1560-1561.","DOI":"10.1126\/science.1260791"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Biggar RJ, Christiansen M, Rostgaard K <i>et al.<\/i> Immunoglobulin subclass levels in patients with non-Hodgkin lymphoma. Int J Cancer. 2009; 124: 2616-2620.","DOI":"10.1002\/ijc.24245"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Jamee M, Hosseinzadeh S, Sharifinejad N <i>et al.<\/i> Comprehensive comparison between 222 CTLA-4 haploinsufficiency and 212 LRBA deficiency patients: a systematic review. Clin Exp Immunol. 2021; 205: 28-43.","DOI":"10.1111\/cei.13600"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Garcia-Perez JE, Baxter RM, Kong DS <i>et al.<\/i> CTLA4 message reflects pathway disruption in monogenic disorders and under therapeutic blockade. Front Immunol. 2019; 10: 998.","DOI":"10.3389\/fimmu.2019.00998"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Hoshino A, Tanita K, Kanda K <i>et al.<\/i> High frequencies of asymptomatic Epstein-Barr virus viremia in affected and unaffected individuals with CTLA4 mutations. Clin Immunol. 2018; 195: 45-48.","DOI":"10.1016\/j.clim.2018.07.012"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Greil C, Roether F, La Ros\u00e9e P <i>et al.<\/i> Rescue of cytokine storm due to HLH by hemoadsorption in a CTLA4-deficient patient. J Clin Immunol. 2017; 37: 273-276.","DOI":"10.1007\/s10875-017-0377-7"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Egg D, Schwab C, Gabrysch A <i>et al.<\/i> Increased risk for malignancies in 131 affected CTLA4 mutation carriers. Front Immunol. 2018; 9: 2012.","DOI":"10.3389\/fimmu.2018.02012"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Oyama T, Yamamoto K, Asano N <i>et al.<\/i> Age-related EBV-associated B-cell lymphoproliferative disorders constitute a distinct clinicopathologic group: a study of 96 patients. Clin Cancer Res. 2007; 13: 5124-5132.","DOI":"10.1158\/1078-0432.CCR-06-2823"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Nicolae A, Pittaluga S, Abdullah S <i>et al.<\/i> EBV-positive large B-cell lymphomas in young patients: a nodal lymphoma with evidence for a tolerogenic immune environment. Blood. 2015; 126: 863-872.","DOI":"10.1182\/blood-2015-02-630632"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Hong JY, Yoon DH, Suh C <i>et al.<\/i> EBV-positive diffuse large B-cell lymphoma in young adults: is this a distinct disease entity? Ann Oncol. 2015; 26: 548-555.","DOI":"10.1093\/annonc\/mdu556"}],"container-title":["Journal of Clinical and Experimental Hematopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/62\/1\/62_21026\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,12]],"date-time":"2022-03-12T04:24:01Z","timestamp":1647059041000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/62\/1\/62_21026\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.3960\/jslrt.21026","relation":{},"ISSN":["1346-4280","1880-9952"],"issn-type":[{"value":"1346-4280","type":"print"},{"value":"1880-9952","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022]]},"article-number":"21026"}}